NovoCure Ltd — Director's Dealing 2019

May 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-05-21

Reporting Person: Madden Martin J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-21	Ordinary Shares	M	8906	$48.87	Acquired	8906	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-21	Restricted Stock Units	$0.00	M	8906	Disposed		Ordinary Shares (8906)	Direct

Footnotes

F1: Fully vested as of the date hereof.